Changes of Dopamine Turnover in the Progression of Parkinson's Disease as Measured by Positron Emission Tomography: Their Relation to Disease-Compensatory Mechanisms
暂无分享,去创建一个
Vesna Sossi | James E. Holden | V. Sossi | J. Holden | M. Schulzer | T. Ruth | R. de la Fuente-Fernández | J. Stoessl | Thomas J. Ruth | Michael Schulzer | Jon Stoessl | Raúl de la Fuente-Fernández
[1] V. Sossi,et al. Increase in Dopamine Turnover Occurs Early in Parkinson's Disease: Evidence from a New Modeling Approach to PET 18F-Fluorodopa Data , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[3] R. Hardie,et al. Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F] dopa PET , 1999, Journal of neurology, neurosurgery, and psychiatry.
[4] V. Sossi,et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.
[5] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] J C Mazziotta,et al. 6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structures , 1990, Journal of neuroscience research.
[7] V Sossi,et al. A Reversible Tracer Analysis Approach to the Study of Effective Dopamine Turnover , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] P. Seeman,et al. Dopamine receptors and transporters in Parkinson's disease and schizophrenia , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[10] M Schulzer,et al. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. , 2001, Annals of neurology.
[11] J. Cano,et al. Increase in dopamine turnover and tyrosine hydroxylase enzyme in hippocampus of rats fed on low selenium diet , 1995, Journal of neuroscience research.
[12] Vesna Sossi,et al. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover , 2001 .
[13] B. Osuntokun,et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria , 1988, Neurology.
[14] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[15] J S Rakshi,et al. Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET , 1998, Journal of neurology, neurosurgery, and psychiatry.
[16] V. Sossi,et al. Effect of Dopamine Loss and the Metabolite 3-O-Methyl-[18F]Fluoro-dopa on the Relation between the 18F-Fluorodopa Tissue Input Uptake Rate Constant Kocc and the [18F]Fluorodopa Plasma Input Uptake Rate Constant Ki , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] T J Spinks,et al. Physical performance of a positron tomograph for brain imaging with retractable septa. , 1992, Physics in medicine and biology.
[18] H. Kimura,et al. Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.
[19] D B Calne,et al. Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. , 1991, Archives of neurology.
[20] Paola Piccini,et al. The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins , 1999, Annals of neurology.
[21] A. Kishore,et al. Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family , 1996, Neurology.
[22] J. Holden,et al. 6‐[18F]fluoro‐L‐DOPA PET studies of the turnover of dopamine in MPTP‐induced parkinsonism in monkeys , 1998, Synapse.
[23] T. Aigner,et al. New rapid analysis method demonstrates differences in 6-[18F] fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[24] V Sossi,et al. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] V. Sossi,et al. Quantitative comparison of three- and two-dimensional PET with human brain studies. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[27] S. Kish,et al. Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease , 1992, Journal of neurochemistry.